Global Tuberculosis (TB) Diagnostics 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR062507302

Publication Date:

June 25, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Tuberculosis (TB) Diagnostics market size was valued at US$ 2953 million in 2024 and is forecast to a readjusted size of USD 3977 million by 2031 with a CAGR of 4.4% during review period.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report is a detailed and comprehensive analysis for global Tuberculosis (TB) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tuberculosis (TB) Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis (TB) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
麻豆原创 segment by Application
Diagnostic Laboratories
Hospitals
麻豆原创 segment by players, this report covers
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin, and global market share of Tuberculosis (TB) Diagnostics from 2020 to 2025.
Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Tuberculosis (TB) Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis (TB) Diagnostics.
Chapter 13, to describe Tuberculosis (TB) Diagnostics research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Tuberculosis (TB) Diagnostics by Type
1.3.1 Overview: Global Tuberculosis (TB) Diagnostics 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Tuberculosis (TB) Diagnostics Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Culture-Based Diagnostics
1.3.4 Sputum Smear Microscopy
1.3.5 Rapid Molecular Diagnostics
1.3.6 Others
1.4 Global Tuberculosis (TB) Diagnostics 麻豆原创 by Application
1.4.1 Overview: Global Tuberculosis (TB) Diagnostics 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Diagnostic Laboratories
1.4.3 Hospitals
1.5 Global Tuberculosis (TB) Diagnostics 麻豆原创 Size & Forecast
1.6 Global Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast by Region
1.6.1 Global Tuberculosis (TB) Diagnostics 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Tuberculosis (TB) Diagnostics 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Tuberculosis (TB) Diagnostics 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Tuberculosis (TB) Diagnostics 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Tuberculosis (TB) Diagnostics 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Tuberculosis (TB) Diagnostics 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Tuberculosis (TB) Diagnostics 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions
2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions
2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Roche Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions
2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 BD Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions
2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Hologic
2.6.1 Hologic Details
2.6.2 Hologic Major Business
2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions
2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Hologic Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 BioMerieux
2.8.1 BioMerieux Details
2.8.2 BioMerieux Major Business
2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 BioMerieux Recent Developments and Future Plans
2.9 Hain Lifescience
2.9.1 Hain Lifescience Details
2.9.2 Hain Lifescience Major Business
2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Hain Lifescience Recent Developments and Future Plans
2.10 Oxford Immunotec
2.10.1 Oxford Immunotec Details
2.10.2 Oxford Immunotec Major Business
2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Oxford Immunotec Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Tuberculosis (TB) Diagnostics by Company Revenue
3.2.2 Top 3 Tuberculosis (TB) Diagnostics Players 麻豆原创 Share in 2024
3.2.3 Top 6 Tuberculosis (TB) Diagnostics Players 麻豆原创 Share in 2024
3.3 Tuberculosis (TB) Diagnostics 麻豆原创: Overall Company Footprint Analysis
3.3.1 Tuberculosis (TB) Diagnostics 麻豆原创: Region Footprint
3.3.2 Tuberculosis (TB) Diagnostics 麻豆原创: Company Product Type Footprint
3.3.3 Tuberculosis (TB) Diagnostics 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Tuberculosis (TB) Diagnostics Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Tuberculosis (TB) Diagnostics Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Tuberculosis (TB) Diagnostics 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Tuberculosis (TB) Diagnostics 麻豆原创 Size by Application (2020-2031)
6.3 North America Tuberculosis (TB) Diagnostics 麻豆原创 Size by Country
6.3.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Tuberculosis (TB) Diagnostics 麻豆原创 Size by Country
7.3.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics 麻豆原创 Size by Region
8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Tuberculosis (TB) Diagnostics 麻豆原创 Size by Country
9.3.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics 麻豆原创 Size by Country
10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Tuberculosis (TB) Diagnostics 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Tuberculosis (TB) Diagnostics 麻豆原创 Drivers
11.2 Tuberculosis (TB) Diagnostics 麻豆原创 Restraints
11.3 Tuberculosis (TB) Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Tuberculosis (TB) Diagnostics Industry Chain
12.2 Tuberculosis (TB) Diagnostics Upstream Analysis
12.3 Tuberculosis (TB) Diagnostics Midstream Analysis
12.4 Tuberculosis (TB) Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.